A2A Receptor Activation Attenuates Hypertensive Cardiac Remodeling via Promoting Brown Adipose Tissue-Derived FGF21

Cell Metabolism
Cheng-Chao RuanPing-Jin Gao

Abstract

Adipocytes play important roles in regulating cardiovascular health and disease. However, the molecular mechanism underlying the endocrine role of brown adipose tissue (BAT) in pathological cardiac remodeling remains unknown. Herein we show that adenosine A2A receptor (A2AR) knockout (A2ARKO) causes interscapular BAT (iBAT) dysfunction, leading to accelerated cardiac remodeling in hypertension compared with wild-type (WT) mice. Surgical iBAT depletion induces dramatic cardiac remodeling in WT but not in A2ARKO hypertensive mice. AMPK/PGC1α signaling-induced fibroblast growth factor 21 (FGF21) in brown adipocytes is required for A2AR-mediated inhibition of hypertensive cardiac remodeling. Recombinant FGF21 administration improves cardiac remodeling in iBAT-depleted hypertensive mice. More importantly, brown adipocyte-specific A2ARKO inhibits FGF21 production and accelerates cardiac damage in hypertension. Consistently, brown adipocyte-specific FGF21 knockout abolishes the effects of A2AR agonism in attenuating hypertensive cardiac remodeling. Our findings reveal a distinctive endocrine role of BAT in hypertensive cardiac remodeling via activating A2AR/FGF21 pathway.

Citations

Jul 13, 2019·Nature Reviews. Endocrinology·Ludger Scheja, Joerg Heeren
Apr 21, 2020·Expert Opinion on Therapeutic Targets·Zhuo-Hang ZhangYuan-Guo Zhou
Aug 9, 2020·Nature Reviews. Endocrinology·Leiluo GengAimin Xu
Jul 22, 2019·International Journal of Molecular Sciences·Donghwan KimYoungsup Song
Sep 20, 2018·Current Hypertension Reports·Eashita DasHoon-Ki Sung
Aug 5, 2020·Nature Metabolism·Robyn M MurphyMark A Febbraio
Nov 25, 2020·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·He ZhangXuhui Liu
Jan 19, 2021·American Journal of Physiology. Endocrinology and Metabolism·Rafael C GasparVitor R Muñoz
Feb 14, 2021·Cellular and Molecular Life Sciences : CMLS·Rafael FrancoLeonardo Pardo
Feb 5, 2021·International Journal of Molecular Sciences·Aimilia Eirini PapathanasiouHelen Christou
Mar 14, 2021·Reviews in Endocrine & Metabolic Disorders·Aleix Gavaldà-NavarroFrancesc Villarroya
Mar 25, 2021·Nature Reviews. Molecular Cell Biology·Paul Cohen, Shingo Kajimura
Jun 3, 2021·International Journal of Molecular Sciences·Bruna B BrandãoAtefeh Rabiee
Jul 9, 2021·The Journal of Experimental Medicine·Yu-Wen ChengPing-Jin Gao
Feb 13, 2021·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tian LanJiao Guo
Oct 10, 2021·Nature Reviews. Endocrinology·Farnaz ShamsiYu-Hua Tseng
Feb 24, 2020·Biochemical and Biophysical Research Communications·Yan-Ping ZhouPing-Jin Gao
Jun 28, 2021·Diabetes & Metabolism Journal·Okamatsu-Ogura Yuko, Masayuki Saito
Jun 27, 2020·Cell Metabolism·Thorsten GnadAlexander Pfeifer
Dec 24, 2021·Chinese Medical Journal·Ying ZhangHua-Ting Li
Jan 9, 2022·Current Obesity Reports·Felix T Yang, Kristin I Stanford

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.